The graph represents a network of 1,138 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Friday, 12 July 2019 at 22:02 UTC.
The requested start date was Thursday, 11 July 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.
The tweets in the network were tweeted over the 70-day, 15-hour, 7-minute period from Wednesday, 01 May 2019 at 00:44 UTC to Wednesday, 10 July 2019 at 15:51 UTC.
Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.
There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".
The graph is directed.
The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.
The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.
Author Description
Vertices : 1138
Unique Edges : 1133
Edges With Duplicates : 759
Total Edges : 1892
Number of Edge Types : 3
Mentions : 1139
Tweet : 599
Replies to : 154
Self-Loops : 599
Reciprocated Vertex Pair Ratio : 0.0102354145342886
Reciprocated Edge Ratio : 0.0202634245187437
Connected Components : 325
Single-Vertex Connected Components : 236
Maximum Vertices in a Connected Component : 203
Maximum Edges in a Connected Component : 426
Maximum Geodesic Distance (Diameter) : 13
Average Geodesic Distance : 3.754614
Graph Density : 0.000762806571729322
Modularity : 0.568142
NodeXL Version : 1.0.1.413
Top Domains
Top Word Pairs in Tweet in Entire Graph:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています [187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが [187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品 [187] それを一般生活にある食品,食事療法などで [187] 食事療法などで,大きく変えて [187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています [187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に [186] satoruo,がんと免疫については [170] bristol,myers [137] opdivo,fails Top Word Pairs in Tweet in G1:
[84] opdivo,fails [81] bristol,myers [74] brain,cancer [59] opdivo,nivolumab [58] late,stage [54] cancer,trial [53] stage,brain [51] bristol,myers' [50] myers',opdivo [47] fails,late Top Word Pairs in Tweet in G2:
[187] がんと免疫については,以前にバズフィードに解説記事を書いています [187] 以前にバズフィードに解説記事を書いています,免疫はたしかにがん治療に重要なのですが [187] 免疫はたしかにがん治療に重要なのですが,それを一般生活にある食品 [187] それを一般生活にある食品,食事療法などで [187] 食事療法などで,大きく変えて [187] 大きく変えて,がん細胞を殺せるような変化を起こすことは困難であることがわかっています [187] がん細胞を殺せるような変化を起こすことは困難であることがわかっています,記事をご参考に [186] satoruo,がんと免疫については [38] ã,ã [6] ã,œã Top Word Pairs in Tweet in G3:
[24] bmy,opdivo [18] opdivo,fails [16] 1st,line [14] fails,1st [14] glioblastoma,tough [14] tough,cancer [14] cancer,crack [14] crack,today [14] today,s [14] s,failure Top Word Pairs in Tweet in G4:
[33] #opdivo,#nivolumab [23] #rituximab,#capecitabina [22] #caracas,#rituximab [22] #capecitabina,#xeloda [22] #xeloda,#taxol [22] #taxol,#nexavar [22] #nexavar,#zoldonat [22] #zoldonat,#zoladex [22] #zoladex,#opdivo [22] #nivolumab,#docetaxel Top Word Pairs in Tweet in G5:
[60] 2,kutusu [60] kutusu,28 [60] 28,bin [60] bin,tl'den [60] tl'den,satılan [60] satılan,ve [60] ve,ay [60] ay,kullanılmak [60] kullanılmak,zorunda [60] zorunda,opdivo Top Word Pairs in Tweet in G6:
[25] checkmate,459 [22] overall,survival [20] results,checkmate [20] 459,trial [20] trial,show [20] show,nivolumab [20] nivolumab,improve [20] improve,overall [20] survival,compared [20] compared,sorafenib Top Word Pairs in Tweet in G7:
[7] bristol,myers [5] myers,squibb [4] bmsnews,#media [4] phase,3 [4] immuno,oncology [4] bms,opdivo [4] opdivo,fails [4] bmsnews,announced [4] opdivo,nivolumab [4] nivolumab,opdivo Top Word Pairs in Tweet in G9:
[18] オプジーボの副作用報道,従来も記載 [18] 従来も記載,認識されていた下垂体機能障害を [18] 認識されていた下垂体機能障害を,重大な副作用 [18] 重大な副作用,に格上げしたものであり [18] に格上げしたものであり,その頻度の低さ [18] その頻度の低さ,適切に検査で発見し処置可能であることを考えれば [18] 適切に検査で発見し処置可能であることを考えれば,その効果を天秤に計ると騒ぎすぎだと感じます [17] biotechmania,オプジーボの副作用報道 Top Word Pairs in Tweet in G10:
[14] il,12 [13] controlled,il [11] opdivo,nivolumab [11] combination,trial [10] 12,plus [10] plus,opdivo [10] phase,1 [10] 1,combination [7] brain,cancer [7] combo,data Top Replied-To in Entire Graph:
Top Replied-To in G3:
Top Replied-To in G4:
Top Replied-To in G5:
Top Replied-To in G7:
Top Replied-To in G8:
Top Replied-To in G10:
Top Mentioned in Entire Graph:
Top Mentioned in G1:
Top Mentioned in G2:
Top Mentioned in G3:
Top Mentioned in G4:
Top Mentioned in G5:
Top Mentioned in G6:
Top Mentioned in G7:
Top Mentioned in G8:
Top Mentioned in G9:
Top Mentioned in G10:
Top Tweeters in Entire Graph:
Top Tweeters in G1:
Top Tweeters in G2:
Top Tweeters in G3:
Top Tweeters in G4:
Top Tweeters in G5:
Top Tweeters in G6:
Top Tweeters in G7:
Top Tweeters in G8:
Top Tweeters in G9:
Top Tweeters in G10: